| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ropivacaine 0.2% (Actavis) 400 mg/200 mL injection, 200 mL bag |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Ropivacaine (Pfizer) 200 mg/100 mL injection, 100 mL bag |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Ropibam 0.2% (ropivacaine hydrochloride 40 mg / 20 mL) injection, 20 mL ampoule (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Ropivacaine 1% (Kabi) 200 mg/20 mL injection, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Ropivacaine 0.2% (Actavis) 40 mg/20 mL injection, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Ropivacaine 1% (Actavis) 200 mg/20 mL injection, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Naropin 0.2% with Fentanyl 400 microgram/100 mL injection, 100 mL bag |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Ropibam 1% 200 mg/20 mL injection, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Ropivacaine (Sandoz) 40 mg/20 mL injection, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Ropivacaine 0.75% (Actavis) 75 mg/10 mL injection, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Naropin 0.2% with Fentanyl 200 microgram/100 mL injection, 100 mL bag |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Ropibam 1% 100 mg/10 mL injection, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Ropivacaine 0.75% (Kabi) 75 mg/10 mL injection, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Optiray-320 678 mg (iodine 320 mg)/mL injection, 200 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Optiray-350 741 mg (iodine 350 mg)/mL injection, 150 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Optiray-350 741 mg (iodine 350 mg)/mL injection, 200 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Optiray-350 741 mg (iodine 350 mg)/mL injection, 20 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Naropin 0.5% 100 mg/20 mL injection, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Naropin 0.5% 50 mg/10 mL injection, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Kanuma 20 mg/10 mL injection, 10 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Voluven injection, 500 mL bottle |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Voluven injection, 500 mL bag |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Zoledronic Acid (Apo) 4 mg/100 mL injection, 100 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Repatha 420 mg/3.5 mL injection, 3.5 mL cartridge |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp 15 microgram/0.38 mL injection, 0.38 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp 50 microgram/0.5 mL injection, 0.5 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp 30 microgram/0.3 mL injection, 0.3 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp 10 microgram/0.4 mL injection, 0.4 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp 200 microgram/0.4 mL injection, 0.4 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp with Automatic Needle Guard 200 microgram/0.4 mL injection, 0.4 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp with Automatic Needle Guard 300 microgram/0.6 mL injection, 0.6 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp with Automatic Needle Guard 15 microgram/0.38 mL injection, 0.38 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp 300 microgram/0.6 mL injection, 0.6 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp with Automatic Needle Guard 500 microgram/mL injection, syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp 500 microgram/mL injection, pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Gonal-F Pen (follitropin alfa 32.76 microgram / 0.75 mL) injection, 0.75 mL pen device (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp Sureclick 40 microgram/0.4 mL injection, 0.4 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Gonal-F Pen 300 units (21.84 microgram)/0.5 mL injection, 0.5 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp Sureclick 60 microgram/0.3 mL injection, 0.3 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp Sureclick (darbepoetin alfa 80 microgram / 0.4 mL) injection, 0.4 mL pen device (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp Sureclick 150 microgram/0.3 mL injection, 0.3 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Gonal-F Pen 900 units (65.52 microgram)/1.5 mL injection, 1.5 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp Sureclick 100 microgram/0.5 mL injection, 0.5 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Aranesp Sureclick 20 microgram/0.5 mL injection, 0.5 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Humalog Kwikpen 200 units/mL injection, 3 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Hyoscine Butylbromide (SXP) 20 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Cobal-B12 1 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycodone (WKT) (oxycodone hydrochloride 20 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycone 10 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycodone (Juno) 200 mg/20 mL injection, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycodone (WKT) 10 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycone 20 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycodone (Juno) 20 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycodone (Wockhardt) 10 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycone 200 mg/20 mL injection, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycodone (Wockhardt) 20 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycodone (Juno) 10 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Morphine Sulfate (Pharmalab) 10 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycone 50 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxycodone (Juno) 50 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Oxynorm 50 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Erelzi Auto-Injector (etanercept 50 mg / 1 mL) injection, 1 mL pen device (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Erelzi 50 mg/mL injection, syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
| Erelzi 25 mg/0.5 mL injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|